Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash Flows from Operating Activities:
Net loss	$ (168,748)	$ (326,717)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	8,584	9,734
Net realized gains on the sale of securities	(192,405)	(10,838)
Amortization of investment securities, net	8,789	5,520
Deferred acquisition costs capitalized	(70,818)	(48,382)
Deferred acquisition costs amortized	37,764	37,457
Interest credited on deposit type contracts	16,597	14,244
(Increase) decrease in operating assets:
Investment income due and accrued	6,255	10,909
Reinsurance related assets	(207)	3,484
Pre-paid expenses	(4,277)	32,202
Other assets	(18,225)	2,003
Increase (decrease) in operating liabilities:
Policyowner benefit reserves	389,568	390,000
Advance premiums	11,247	15,740
Other liabilities	14,352	12,037
Accounts payable and accrued expenses	2,796	(24,110)
Net cash provided by operating activities	41,272	123,283
Cash Flows from Investing Activities:
Purchase of fixed income investments	(1,479,152)	(269,208)
Purchase of equity investments	(180,567)	(395,268)
Proceeds from fixed income sales and repayments	154,696	153,393
Proceeds from equity sales and repayments		92,247
Net cash (used in) investing activities	(1,505,023)	(418,836)
Cash Flows from Financing Activities:
Receipts on deposit-type contracts	579,215	441,382
Withdrawals on deposit-type contracts	(137,761)	(74,577)
Proceeds received from exercise of warrants, net of costs of issuance	54,212	1,881,819
Net cash provided by financing activities	495,666	2,248,624
Net (decrease) increase in cash and cash equivalents	(968,085)	1,953,071
Cash and Cash Equivalents:
Beginning	3,145,745	2,466,526
Ending	$ 2,177,660	$ 4,419,597